Literature DB >> 15188072

Natural history of acute symptomatic hepatitis type C.

M Wawrzynowicz-Syczewska1, J Kubicka, Z Lewandowski, A Boroń-Kaczmarska, M Radkowski.   

Abstract

BACKGROUND: Spontaneous clearance of hepatitis C virus (HCV) after acute hepatitis C, and the course of chronic HCV infection in patients who did not clear the virus, were studied. PATIENTS AND METHODS: Patients with acute C or non-A, non-B hepatitis who were hospitalized between 1988 and 1998 were called for evaluation in 2001. They were tested for anti-HCV, serum HCV-RNA, HCV-RNA in peripheral blood mononuclear cells (PBMC) and liver enzymes. A liver biopsy was performed on chronically infected patients. The course of acute hepatitis C was compared between HCV-RNA-positive and negative subjects to look for factors that might influence spontaneous viral clearance. Factors influencing more progressive liver disease were analyzed in chronic hepatitis C.
RESULTS: Out of 159 acute hepatitis C patients, 77 (48.4%) participated in the study, and the median observation time was 8 years. Spontaneous clearance of serum HCV was found in 23 subjects (29.9%), but in two cases HCV-RNA was detected in peripherical blood mononuclear cells (PBMC). Only three patients negative for HCV-RNA in serum and PBMC lost anti-HCV. Severity of acute HCV infection and previous alcohol abuse seemed to influence resolution. In non-alcoholic patients, older age at time of primary infection was a significant predictor of virus clearance. In chronic hepatitis C, more than 75% of patients had minimal or mild activity in biopsy, but 40% had advanced fibrosis. Older age at infection, male gender, alcohol abuse, and higher iron content were connected with advanced fibrosis.
CONCLUSION: Studies on HCV infection resolution should include at least PBMC testing for HCV-RNA. A healthy carrier state of HCV can be discussed. A longer observation time increased the likelihood of seroreversion. Fibrosis in chronic hepatitis C probably is not a direct result of inflammatory activity. Copyright Urban and Vogel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15188072     DOI: 10.1007/s15010-004-3062-8

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  9 in total

1.  Impact of host responses on control of hepatitis C virus infection in Chinese blood donors.

Authors:  Tingting Li; Zixuan Chen; Jinfeng Zeng; Jingang Zhang; Wenjing Wang; Ling Zhang; Xin Zheng; Lifang Shuai; Paul Klenerman; Jean-Pierre Allain; Chengyao Li
Journal:  Biochem Biophys Res Commun       Date:  2011-10-29       Impact factor: 3.575

Review 2.  Pharmacological interventions for acute hepatitis C infection: an attempted network meta-analysis.

Authors:  Maria Kalafateli; Elena Buzzetti; Douglas Thorburn; Brian R Davidson; Emmanuel Tsochatzis; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2017-03-13

3.  Purification and application of C-terminally truncated hepatitis C virus E1 proteins expressed in Escherichia coli.

Authors:  Jing Liu; Li-Xin Zhu; Yu-Ying Kong; Guang-Di Li; Yuan Wang
Journal:  World J Gastroenterol       Date:  2005-01-28       Impact factor: 5.742

4.  Distinguishing acute from chronic and resolved hepatitis C virus (HCV) infections by measurement of anti-HCV immunoglobulin G avidity index.

Authors:  S Klimashevskaya; A Obriadina; T Ulanova; G Bochkova; A Burkov; A Araujo; Susan L Stramer; Leslie H Tobler; Michael P Busch; Howard A Fields
Journal:  J Clin Microbiol       Date:  2007-08-22       Impact factor: 5.948

5.  Glances in Immunology of HIV and HCV Infection.

Authors:  Maria Giovanna Quaranta; Benedetta Mattioli; Stefano Vella
Journal:  Adv Virol       Date:  2012-06-07

6.  Pharmacological interventions for acute hepatitis C infection.

Authors:  Maria Kalafateli; Elena Buzzetti; Douglas Thorburn; Brian R Davidson; Emmanuel Tsochatzis; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2018-12-03

Review 7.  Is sustained virological response a marker of treatment efficacy in patients with chronic hepatitis C viral infection with no response or relapse to previous antiviral intervention?

Authors:  Kurinchi S Gurusamy; Edward Wilson; Ronald L Koretz; Victoria B Allen; Brian R Davidson; Andrew K Burroughs; Christian Gluud
Journal:  PLoS One       Date:  2013-12-12       Impact factor: 3.240

8.  Hepatitis C viremia patterns in incident hepatitis C infection and one year later in 150 prospectively tested persons who inject drugs.

Authors:  Marianne Alanko Blomé; Per Björkman; Vilma Molnegren; Peter Höglund; Anders Widell
Journal:  PLoS One       Date:  2014-05-15       Impact factor: 3.240

9.  Alcohol use disorders and the risk of progression of liver disease in people with hepatitis C virus infection - a systematic review.

Authors:  Laura Llamosas-Falcón; Kevin D Shield; Maya Gelovany; Jakob Manthey; Jürgen Rehm
Journal:  Subst Abuse Treat Prev Policy       Date:  2020-06-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.